Two patients experienced transient anti-glioma responses, with one patient showing decreased IL13Rα2 expression in tumour tissue after treatment and the other exhibiting an increase in tumour necrosis volume at the administration site on MRI (174). Here, IL13RA2 is linked to neoplasm.